Pneumonia
0-1: low risk
2: Probably admission
3: Admission (Mortality 30-d 22%)
Shortness of breath (Cardiac-HF)
• ACE inhibitors*- monitor as above
• Beta-blockers
• Spironolactone= aldosterone antagonist (NYHA class 2-4)
-Monitor serum potassium and renal function
• Digoxin if in sinus rhythm + moderate symptoms despite optimization
-Check digoxin level periodically
• The combination of sacubitril/valsartan (Entresto) is called an angiotensin receptor/neprilysin inhibitor (ARNI)
• New guidelines recommend ARNI for patients with HFrEF who have symptoms that meet NYHA class II or III heart failure
Meds with positive impact on mortality in CHF:
ACS: STEMI, NSTEMI, Angina
• ABC:
-Airway
-B: Oxygen and sat
-C: ASA 160 mg stat, vitals, ECG, 2 IV lines
• IV access, Cardiac monitoringIF positive for MI:
• M orphine 2-4 mg IV prn
• O 2: 4 L/Min (Only if patient is hypoxic. No benefit if the patient is not hypoxic)
• N itroglycerin: spray SL or TAB SL Given up to 3 times, 5 min interval if there are no contraindications (Cialis or Viagra within the last 24 h, hypotensive, inferior wall infarct)
• ASA 160- 325 mg orally; Ask for any allergy - if ASA is contraindicated give Clopidogrel (Plavix) 75 mg alternatively.
• 2nd Antiplatelet: Clopidogrel, Ticagrelor, Prasugrel (Give to all; STEMI, and Unstable angina which may become NSTEMI)
Adjunctive: BB (if contraind, CCB) and Heparin
Note: For any MI or Angio-> give two different types of Antiplatelet (in which Prasugrel is one of them)
*NSTEMI: LMW Heparin and Glycoprotein IIb/IIIa inhibitors (Eptifibatide, Abciximab)
LASTLY: ADMIT to ICU or CCU!!! and cardiology consult.